Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
Date:1/29/2008

- $161.5 million in cash at year end; no equity financings expected in 2008 - Significant progress in lead lysosomal disease programs to continue in 2008; latest data for all programs to be presented at ACMG meeting in March - Expansion of research and development investment in pharmacological chaperone platform planned for targets beyond lysosomal diseases in 2008

CRANBURY, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company developing small molecule, orally- active pharmacological chaperones for the treatment of human genetic diseases, today announced financial results for the fourth quarter and full year of 2007. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (GAAP), Amicus announced a net loss attributable to common stockholders of $0.53 per share ($0.48 per share on a non-GAAP basis) for the three months ended December 31, 2007. For the year ended December 31, 2007, on a GAAP basis, the net loss attributable to common stockholders was $3.14 per share ($2.80 per share on a non-GAAP basis). As of December 31, 2007, cash, cash equivalents, and marketable securities totaled $161.5 million. Amicus Chief Financial Officer James Dentzer noted that: "We have ended 2007 in a strong financial position. We have several years of cash on hand, and this is further enhanced by the cost sharing and expected milestones from our partnership with Shire Human Genetic Therapies. As a result, we do not expect to raise cash from any equity financings in 2008."

In November 2007, Amicus entered into a strategic collaboration with Shire Human Genetic Therapies, a business unit of Shire plc, to jointly develop Amicus' three lead pharmacological
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
2. Amicus Therapeutics to Host R&D Day
3. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
4. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
5. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
6. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
7. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
8. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
9. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
10. Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
11. Arno Therapeutics Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...sit Detroit , (Vocus) Nov...bassador for International Investment, and Chairma...What: Ambassador Appia is available to meet with p...opted by France to further develop the financial, ...evelopment., , ,When: Available for Interview on W...
(Date:11/24/2009)...Newswire/ -- Two more prestigious universities hav...nline job board and careers site for life science ...versity are now members of the job board, joining ... ,, The job board, www.biocareercenter.com , i...ile there are hundreds of life science career site...
(Date:11/24/2009)..., November 24 deCODE,gen...t has received notice from,the Nasdaq Stock Market...e,suspended as of November 30, 2009 and a Form 25-... Commission, which will remove deCODE,s common sto...s an appeal to the Nasdaq,Listing Qualifications P...
(Date:11/24/2009)...nt grew by 29,000 jobs in October, and the field ...ing the U.S. recession. However, clinics and speci...ms are coming closer to having to actually cut med... (Vocus) November 24, 2009...tober despite the shedding of jobs in most other a...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...hcare Facilities across North ...- Halogen Software Inc., the leading,provider of w...t software,today announced that strong fourth quar... lead as the solution of choice for the healthcare... a number of key accounts,this past quarter includ...
...Xinhua-PRNewswire-FirstCall/ --,Kiwa Bio-Tech Prod...reports,sharply improved volume of bio-fertilizer ...io-Tech Products (Shandong) Co., Ltd. ("Kiwa,Shand...ting in the,bio-fertilizer industry, sold 114 tons...r of 2007 as compared with 14 tons in the same per...
...more competition from private ...nture capitalists will largely,direct their invest...he,coming year, while China and India remain hot d...nt survey by the U.S. audit, tax and advisory,firm...talists, entrepreneurs, corporate,buyers, investme...
Other Biology Technology:Halogen Advances its Lead in Providing Employee Performance and Talent Management Solutions for the Healthcare Market 2Kiwa Bio-Tech Ships 114 Tons of Bio-Fertilizer in Fourth Quarter of 2007 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 2Venture Capitalists Bullish on Greentech and Biotech, KPMG Study Says 3
(Date:11/26/2009)... Ecologists have at last worked out a way of using...size of bird populations. This is the first time s...translated into accurate estimates of bird species... in the British Ecological Society,s Journal of A...t could lead to a major advance in our ability to ...
(Date:11/26/2009)..., Heidelberg, 27 November 2009 What are the ba...ts required to produce a cell that can survive on ...a cell, and understand how an entire organism func...tions that scientists in a partnership between the...eidelberg, Germany, and the Centre de Regulacio Ge...
(Date:11/25/2009)... Ghrelin, a hormone produced in the stomach, may b...pment of Parkinson,s disease, Yale School of Medic...ecent issue of the Journal of Neuroscience . , ... dopamine neurons in an area of the midbrain known... dopamine production. Reduced production of dopam...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 1PharmaTelevision Turns the Media Spotlight Upon BIO Europe 14467 2Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 1Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 2Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 3Sharp HealthCare Selects MEDais Pinpoint Review to Prevent Readmissions 5452 4Record Revenue Growth for Medical Device Software Consulting Firm Full Spectrum Software 14465 1Record Revenue Growth for Medical Device Software Consulting Firm Full Spectrum Software 14465 2
...OneWorld Health, the first nonprofit pharmaceutica...ived Orphan Drug Designation from the two leading ...g Administration (FDA) and the European Agency for...paromomycin to treat visceral leishmaniasis (VL). ...a fatal disease transmitted by sand flies, which s...
...frican legal complaint against British drug maker ...nd policies in that country will proceed following...tion Tribunal that will allow the complaint to go ...case; however, the Competition Tribunal issued an ...thcare Foundation (AHF) and several South African ...
...ve discovered a specialized night-vision brain are...rea might enable the birds to navigate by the star...ld through photoreceptor molecules, whose light-se...hers published their findings May 23, 2005, in the...tional Academy of Sciences. The collaboration was ...
Other Biology News:OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case 2Migratory songbirds have a specialized night-vision brain area 2
...software, a multitasking application capable of dy...ing and operation of lab automation workcells easy... modification by programmers. • Users creat...art. If you can build a flowchart, you can write a...
...h demands continue to grow, the need for greater d...ome necessary, especially when discerning very sim...tive C1si Confocal Microscope System gives you a l... not available in conventional confocal systems, w...
...based assay kit provides complete components inclu...nient detection of DNA fragmentation in cultured c...U in the procedure provides greater sensitivity th...s can be analyzed by fluorescence microscopy or fl...
...our Ion Chromatography requirements, IonQuest wil...oped conductivity detector has very high sensitiv...tion to the standard conductivity detector, the Io...lectrochemical, refractive index, UV/Visible, Wave...
Biology Products: